185 related articles for article (PubMed ID: 17537985)
1. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury.
Okamura DM; López-Guisa JM; Koelsch K; Collins S; Eddy AA
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F575-85. PubMed ID: 17537985
[TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
Aslanian AM; Charo IF
Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
[TBL] [Abstract][Full Text] [Related]
3. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
[TBL] [Abstract][Full Text] [Related]
4. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.
Inoue K; Arai Y; Kurihara H; Kita T; Sawamura T
Circ Res; 2005 Jul; 97(2):176-84. PubMed ID: 15961718
[TBL] [Abstract][Full Text] [Related]
6. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro.
Zhang L; Liu HJ; Li TJ; Yang Y; Guo XL; Wu MC; Rui YC; Wei LX
Acta Pharmacol Sin; 2008 Jul; 29(7):847-52. PubMed ID: 18565283
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
[TBL] [Abstract][Full Text] [Related]
9. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.
Uza N; Nakase H; Yamamoto S; Yoshino T; Takeda Y; Ueno S; Inoue S; Mikami S; Matsuura M; Shimaoka T; Kume N; Minami M; Yonehara S; Ikeuchi H; Chiba T
Gut; 2011 Nov; 60(11):1494-505. PubMed ID: 21471570
[TBL] [Abstract][Full Text] [Related]
10. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
[TBL] [Abstract][Full Text] [Related]
11. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.
Kamei M; Yoneda K; Kume N; Suzuki M; Itabe H; Matsuda K; Shimaoka T; Minami M; Yonehara S; Kita T; Kinoshita S
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1801-7. PubMed ID: 17389514
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.
Iwashima Y; Eto M; Hata A; Kaku K; Horiuchi S; Ushikubi F; Sano H
Biochem Biophys Res Commun; 2000 Oct; 277(2):368-80. PubMed ID: 11032732
[TBL] [Abstract][Full Text] [Related]
13. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
15. Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene.
Ling W; Lougheed M; Suzuki H; Buchan A; Kodama T; Steinbrecher UP
J Clin Invest; 1997 Jul; 100(2):244-52. PubMed ID: 9218499
[TBL] [Abstract][Full Text] [Related]
16. Chemokine SR-PSOX/CXCL16 expression in peripheral blood of patients with acute coronary syndrome.
Yang HL; Xu YY; DU LF; Liu CH; Zhao Q; Wei WJ; You Y; Quan ZH
Chin Med J (Engl); 2008 Jan; 121(2):112-7. PubMed ID: 18272035
[TBL] [Abstract][Full Text] [Related]
17. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
Morawietz H
Dtsch Med Wochenschr; 2010 Feb; 135(7):308-12. PubMed ID: 20146162
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction.
Moridaira K; Morrissey J; Fitzgerald M; Guo G; McCracken R; Tolley T; Klahr S
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F209-17. PubMed ID: 12473537
[TBL] [Abstract][Full Text] [Related]
19. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
[TBL] [Abstract][Full Text] [Related]
20. CXCL16/SR-PSOX--a friend or a foe in atherosclerosis?
Sheikine Y; Sirsjö A
Atherosclerosis; 2008 Apr; 197(2):487-95. PubMed ID: 18191863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
